Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cigna Corp.

Start price
Target price
Perf. (%)
€236.40
20.05.23
-
20.05.24
32.01%
02:15

Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
20.05.23
-
20.05.24
-
02:15

Arca Biopharma

Start price
Target price
Perf. (%)
€1.85
20.05.23
-
20.05.24
76.22%
02:15

buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€80.50
20.05.23
-
20.05.24
24.22%
02:15

Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
20.05.23
-
20.05.24
-
02:15

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.05
20.05.23
-
20.05.24
-61.98%
02:15

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.18
31.03.24
€6.00
31.03.25
-31.58%
20.05.24

buy
Capricor Therapeutics Inc

Start price
Target price
Perf. (%)
€5.73
19.05.24
€10.00
-
20.05.24

Protara Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.90
19.05.24
€1.00
19.05.25
-5.52%
20.05.24

Arca Biopharma

Start price
Target price
Perf. (%)
€3.02
19.05.24
€1.00
-
20.05.24

MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.06
19.05.24
€2.00
-
20.05.24

CEL-SCI Corp.

Start price
Target price
Perf. (%)
€1.16
19.05.24
€1.00
-
20.05.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.03
20.05.23
-
20.05.24
177.89%
20.05.24

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€33.15
19.05.23
€40.00
19.05.24
54.24%
20.05.24

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.88
19.05.23
€3.00
19.05.24
-61.56%
20.05.24

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€8.70
11.05.24
€82.00
11.05.25
39.26%
19.05.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
Biolife Solutions Inc

Start price
Target price
Perf. (%)
€18.50
11.05.24
€32.00
11.05.25
8.11%
19.05.24

MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.14
11.05.24
€1.02
11.05.25
30.98%
19.05.24

Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€10.20
11.05.24
€5.00
11.05.25
-7.27%
19.05.24

Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.12
11.05.24
€1.00
11.05.25
-8.33%
19.05.24

Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.83
11.05.24
€1.00
11.05.25
-3.66%
19.05.24

buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€17.30
18.05.23
-
18.05.24
31.79%
19.05.24

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€34.10
18.05.23
-
18.05.24
-22.43%
19.05.24

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€24.45
16.04.24
-
16.05.24
8.94%
17.05.24

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€73.00
16.05.23
€91.88
16.05.24
-14.51%
17.05.24